USE OF 1,25-DIHYDROXYVITAMIN D VALUES IN RATIO WITH PTH AS A PROGNOSTIC BIOMARKER

摘要

The present invention relates to a method for predicting or stratifying the risk of morbidity and/or mortality in a chronic heart failure patient. Levels of 1,25-dihydroxyvitamin D (1,25(OH) 2D) are measured in a biological sample and taken together with parathyroid hormone (PTH) levels to provide a ratio indicative of risk of chronic heart failure morbidity and/or mortality.